Bangkok Noi District Electronic Health Database With Socioeconomic Factors From Bangkok Noi Model Project (BANMOP)

September 1, 2024 updated by: Naris Kitnarong, Siriraj Hospital
Bangkoknoi Model Project (BANMOP) is guided by context-specific health databases to promote the sustainable health and well-being of people living in the Bangkoknoi district. The BANMOP is a prospective cohort project that emphasizes community engagement via electronic databases. Data were collected from households in Bangkoknoi district. Convenience sampling was used and the data were collected via mobile application and a web-based platform, and by face-to-face interviews with well-trained volunteers who were mainly health professionals. The data were categorized by age groups: 0-5, 6-14, 15-21, 22-59, >60 years old, included both individuals and families in five categories: health, environment & disaster, economics, social, and safety.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

A total of 21,286 participants from 42 Bangkoknoi communities accounted for 16.08% of total population of Bangkoknoi district were participated. Forty percent of participants reported having physical health problems. Noncommunicable diseases were dominated by physical health issues as age progressed. Overall, hypertension was the most prevalent health problem at 12.6 % followed by allergic diseases (11%), diabetes mellitus (7.5%), and dyslipidemia (6.1%). Anxiety was the most common mental disorder and gender income disparity is an important issue. Although, 91.6% of participants satisfied with their home environment, but the crowded, cluttered, urban environment caused their dissatisfaction. Forty-two percent reported the problems related to reproductive health such as teen pregnancy (16.72%), family planning and marriage guidance (12.74%), premature sexual transmitted diseases (8.96%) and infertility (3.78%). Subsequently, 17 sub-projects were established to promote the sustainable health and well-being of people in the Bangkoknoi district.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
21286

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The total population of Bangkoknoi district included 132,372 individuals in 48,771 households and (one of the following)

  1. Individuals registered with the Bangkoknoi district and currently reside there.
  2. Individuals who are not registered, but currently reside in the Bangkoknoi district.
  3. Individuals registered with the Bangkoknoi district, but who currently reside outside the district.
  4. Individuals, both Thai and non-Thai citizens, who work in the Bangkoknoi district continuously for at least 30 days.
  5. Individuals who study at schools or universities in the Bangkoknoi district continuously for at least 30 days.

Description

The total population of Bangkoknoi district included 132,372 individuals in 48,771 households.

Inclusion Criteria:

  1. Individuals registered with the Bangkoknoi district and currently reside there.
  2. Individuals who are not registered, but currently reside in the Bangkoknoi district.
  3. Individuals registered with the Bangkoknoi district, but who currently reside outside the district.
  4. Individuals, both Thai and non-Thai citizens, who work in the Bangkoknoi district continuously for at least 30 days.
  5. Individuals who study at schools or universities in the Bangkoknoi district continuously for at least 30 days.

Exclusion Criteria:

  • Individuals who were not willing to participate or answer the questionnaires were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
0 to 5 year-olds
Participants aged between 0-5 year-olds
Behavioral: Health promotion campaigns to correct the health problems
6- 14 year-olds
Participants aged between 6-14 year-olds
Behavioral: Health promotion campaigns to correct the health problems
15-21 year-olds
Participants aged between 15-21 year-olds
Behavioral: Health promotion campaigns to correct the health problems
22-59 year-olds
Participants aged between 22-59 year-olds.
Behavioral: Health promotion campaigns to correct the health problems
equal to and more than 60 year-olds
Participants aged equal to and more than 60 year-olds
Behavioral: Health promotion campaigns to correct the health problems

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
health conditions
Time Frame: 4.5 years from 1st of October 2015 to the 31st of March 2020
survey questionnaires on individual and household health condition
4.5 years from 1st of October 2015 to the 31st of March 2020

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Health-related conditions
Time Frame: 4.5 years from 1st of October 2015 to the 31st of March 2020
survey questionnaires on individual and household health-related condition including environment & disaster, economics, social, and safety
4.5 years from 1st of October 2015 to the 31st of March 2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Siriraj Hospital

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Naris Kitnarong, M.D., M.B.A., Mahidol university

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 5, 2017

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 31, 2020

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
October 30, 2020

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 1, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 1, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 4, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 4, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 1, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • SI002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD could be shared under reasonable request via the website: www.bangkoknoimodel.com

IPD Sharing Time Frame

Since March 2020 to up to 10 years after

IPD Sharing Access Criteria

For non-profit organizations only. For further projects/researches that related to Bangkoknoi area/individuals

IPD Sharing Supporting Information Type

  • SAP
  • CSR

Study Data/Documents

  1. Clinical Study Report

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings